Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand

Cancer Research

Volumn 62, Issue 24, 2002, Pages 7170-7174

  Ehtesham, Moneeb ^a   Kabos, Peter ^a   Gutierrez, Mervin A R ^a   Chung, Nancy H C ^a   Griffith, Thomas S ^b   Black, Keith L ^a   Yu, John S ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; MOUSE; NERVE CELL; NICK END LABELING; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; STEM CELL; TUMOR VOLUME; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BETA-GALACTOSIDASE; BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, NUDE; NEURONS; STEM CELL TRANSPLANTATION; STEM CELLS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0037115671     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Surawicz, T. S., Davis, F., Freels, S., Laws, E. R., Jr., and Menck, H. R. Brain tumor survival: Results from the National Cancer Data Base. J Neurooncol., 40: 151-160. 1998.
2. Aboody, K. S., Brown, A., Rainov, N. G., Bower, K. A., Liu, S., Yang, W., Small, J. E., Herrlinger, U., Ourednik, V., Black, P. M., Breakefield, X. O., and Snyder, E. Y. From the cover: Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proc. Natl. Acad. Sci. USA, 97: 12846-12851, 2000.
3. Ehtesham, M., Kabos, P., Kabosova, A., Neuman, T., Black, K., L., and Yu, J. S. The use of interleukin 12 secreting neural stem cells for the treatment of intracranial glioma. Cancer Res., 62: 5657-5663, 2002.
4. Martens, D. J., Tropepe, V., and van Der Kooy, D. Separate proliferation kinetics of fibroblast growth factor-responsive and epidermal growth factor-responsive neural cells within the embryonic forebrain germinal zone. J. Neurosci., 20, 1085-1095, 2000.
5. Schaack, J., Langer, S., and Guo, X. Efficient selection of recombinant adenoviruses by vectors that express β-galactosidase. J. Virol., 69: 3920-3923, 1995.
6. Griffith, T. S., Anderson, R. D., Davidson, B. L., Williams, R. D., and Ratliff, T. L. Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis. J. Immunol., 165: 2886-2894, 2000.
7. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol, Methods, 65: 55-63, 1983.
8. Samoto, K., Ehtesham, M., Perng, G. C., Hashizume, K., Wechsler, S. L., Nesburn, A. B., Black, K. L., and Yu, J. S. A herpes simplex virus type 1 mutant with γ 34.5 and LAT deletions effectively oncolyses human U87 glioblastomas in nude mice, Neurosurgery, 50: 599-605, 2002.
9. Ehtesham, M., Samoto, K., Kabos, P., Acosta, F. L., Gutierrez, M. A. R., Black, K. L., and Yu, J. S. Treatment of intracranial glioma with in situ interferon-γ and tumor necrosis factor-α gene transfer. Cancer Gene Ther., 9: 925-934, 2002.
10. Sheridan, J. P., Marsters, S. A., Pitti, R. M., Gurney, A., Skubatch, M., Baldwin, D., Ramakrishnam, L., Gray, C. L., Baker, K., Wood, W. I., Goddard, A. D., Godowski, P., and Ashkenazi, A. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science (Wash. DC). 277: 818-821, 1997.
11. Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., DeForge Koumenis, I. L., Lewis, D., Harris, L., Bussiere, J., Koeppen, H., Shahrokh, Z., and Schwall, R. H. Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Investig., 104: 155-162, 1999.
12. Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., Smith, C., Smolak, P., Goodwin, R. G., Rauch, C. T., Schuh, J. C., and Lynch, D. H. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med., 5: 157-163. 1999.
13. Xiao, C., Yang, B. F., Asadi, N., Beguinot, F., and Hao, C. Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation byc-FLIP and PED/PEA-15 in glioma cells. J. Biol. Chem., 277: 25020-25025, 2002.
14. Ashkenazi, A., and Dixit, V. M. Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol., 11: 255-260, 1999.
15. Pan, G., Ni, J., Yu, G., Wei, Y. F., and Dixit, V. M. TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling. FEBS Lett., 424: 41-45. 1998.
16. Hao, C., Beguinot, F., Condorelli, G., Trencia, A., Van Meir, E. G., Yong, V. W., Parney, I. F., Roa, W. H., and Petruk, K. C. Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apoptosis in human malignant glioma cells. Cancer Res., 61: 1162-1170, 2001.
17. Wu, M., Das, A., Tan, Y., Zhu, C., Cui, T., and Wong, M. C. Induction of apoptosis in glioma cell lines by TRAIL/Apo-21. J. Neurosci. Res., 61: 464-470, 2000.
18. Roth, W., Isenmann, S., Naumann, U., Kugler, S., Bahr, M., Dichgans, J., Ashkenazi, A., and Weller, M. Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence neurotoxicity. Biochem. Biophys. Res. Commun., 265: 479-483, 1999.
19. Lee, J., Hampl, M., Albert, P., and Fine, H. A. Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector, Neoplasia, 4: 312-323, 2002.
20. Dewey, R. A., Morrissey, G., Cowsill, C. M., Stone, D., Bolognani, F., Dodd, N. J., Southgate, T. D., Klatzmann, D., Lassmann, H., Castro, M. G., and Lowenstein, P. R. Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implications for clinical trials. Nat, Med., 5: 1256-1263, 1999.